Abstract
Screening with hepatitis B surface antigen (HBsAg) is highly recommended for at-risk individuals. Mutations in the HBsAg can result in an inability to detect the virus during routine screening. We describe a hemodialysis patient found to have high levels of hepatitis B virus (HBV) DNA and HBV antibody but negative HBsAg on two routine assays.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 820-822 |
| Number of pages | 3 |
| Journal | Clinical and Vaccine Immunology |
| Volume | 19 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2012 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Clinical Biochemistry
- Microbiology (medical)
Fingerprint
Dive into the research topics of 'False-negative hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS